Filing summary
Identity and period: The supplied metadata names ABVC Biopharma, Inc., but the filing itself is for Ecology Coatings, Inc. It is a Form 10-Q for the quarter ended June 30, 2015, with nine-month results; the filing does not identify this as ABVC’s report. Financial figures below are as presented in the filing, in dollars.
Business context and reporting period
After filing for Chapter 7 bankruptcy in 2013, the company emerged from bankruptcy-related proceedings using fresh-start accounting in September 2014. It says its post-bankruptcy business is a website selling women’s apparel, acquired through the purchase of Seene LLC assets, including the MeTu name and website. Management cautions that the post-fresh-start results are not comparable with earlier results.
Financial results and liquidity
| Metric | Three months ended June 30, 2015 | Nine months ended June 30, 2015 | Comparable 2014 period |
|---|---|---|---|
| Revenue | $0 | $2,260 | $0 |
| Cost of sales | $0 | $301 | $0 |
| Gross profit | $0 | $1,959 | $0 |
| Operating expenses | $1,500 | $3,370 | $30 and $70, respectively |
| Net loss | $1,500 | $1,411 | $30 and $70, respectively, per statements |
The nine-month gross margin was approximately 86.7% on very low sales. The statements report no interest expense or income taxes. The MD&A gives the 2014 nine-month net loss as $40, conflicting with the financial statements’ $70 figure.
- Cash and working capital: Cash was $2,260 at June 30, 2015, versus zero at September 30, 2014. Current assets were $2,754 and current liabilities were $37,400, a working-capital deficit of $34,646.
- Cash flow: The cash-flow statement reports $2,260 of net cash provided by operating activities and no investing or financing cash flow; 2014 operating cash flow was a $70 outflow. The company reports no interest or income taxes paid.
- Debt and obligations: Balance-sheet liabilities included $7,000 in notes payable, a $9,000 zero-interest related-party note due on demand, and $21,400 of accrued expenses. The $7,000 note is stated to have been due September 24, 2014, but the filing says it is not in default.
- Assets and equity: Total assets were $67,348, including $64,594 of intangible assets; property and equipment were zero. Total equity was $29,948. Common shares outstanding were 54,593,032; 271 preferred shares were outstanding, each convertible into 100,000 common shares and carrying equivalent voting rights.
Changes, outlook, risks and unusual items
- Revenue was $2,260 for the nine months versus none in 2014, but there were no sales in the latest quarter. Management attributed higher expenses to professional fees and operating the company’s administrative activities and website.
- Management states that limited operations and the working-capital deficit raise substantial doubt about the company’s ability to continue as a going concern. It expects to need additional working capital and says future financing is not assured.
- The company had approximately $25,900 of post-bankruptcy tax loss carryforwards; their use may be limited, including under Internal Revenue Code Section 382. A valuation allowance was recorded and no net deferred tax asset was recognized.
- The filing reports no lease commitments, off-balance-sheet arrangements, pending legal proceedings, or subsequent events requiring disclosure. It says contingencies were settled through the bankruptcy process.
- Disclosure controls were deemed ineffective because the small finance staff lacked segregation of duties. No changes in internal control were reported during the quarter.
- Potential dilution and voting concentration merit attention: preferred shares have substantial common conversion and voting rights, and the filing says a reverse split of up to 5,000-for-1 had been authorized and up to 60 million additional common shares could be issued.
- The filing checks “No” for having filed all required Exchange Act reports during the preceding 12 months. It provides no specific financial guidance or quantified operating outlook.
Important facts for investors to verify
- Confirm the issuer: the filing is for Ecology Coatings, Inc., not the ABVC Biopharma, Inc. named in the request metadata.
- Reconcile the reported operating cash flow with the net loss and working-capital adjustments, and confirm the source and collection of the $2,260 revenue/cash balance.
- Resolve the $40 versus $70 discrepancy in the MD&A and financial statements for the comparable nine-month 2014 net loss.
- Confirm the status and repayment terms of the $7,000 note whose stated due date predates the reporting period.
- Assess near-term funding needs, going-concern uncertainty, the preferred-stock conversion/voting rights, and potential share issuance or reverse split.